We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Tyra Biosciences Inc is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Tyra Biosciences Inc is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer.
Tyra Biosciences Announces Preclinical Proof-of-Concept Results with TYRA-300 in Hypochondroplasia (HCH) PR Newswire CARLSBAD, Calif., July 2, 2024 - In a preclinical HCH model, TYRA-300...
Tyra Biosciences to Present at Upcoming Investor Conferences PR Newswire CARLSBAD, Calif., May 23, 2024 CARLSBAD, Calif., May 23, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.5 | 2.55232261358 | 19.59 | 22.2 | 19.42 | 107757 | 20.9515457 | CS |
| 4 | 4.55 | 29.2792792793 | 15.54 | 22.2 | 15.25 | 178784 | 17.95522893 | CS |
| 12 | 0.8 | 4.14722654225 | 19.29 | 22.2 | 15.25 | 158706 | 17.9339382 | CS |
| 26 | 6.98 | 53.2418001526 | 13.11 | 22.2 | 12.485 | 149665 | 17.55444941 | CS |
| 52 | 4.79 | 31.3071895425 | 15.3 | 22.2 | 10.38 | 107878 | 16.26178919 | CS |
| 156 | -9.81 | -32.8093645485 | 29.9 | 31.36 | 4.93 | 106186 | 14.96194306 | CS |
| 260 | -9.81 | -32.8093645485 | 29.9 | 31.36 | 4.93 | 106186 | 14.96194306 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
